Samsara BioCapital’s Jiya Acquisition Corp. Class A Common Stock JYAC Stock Holding History

Samsara BioCapital’s Portfolio JYAC Stock Details JYAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-507,041	Closed	-$5.05M	–	56
2022 Q3	$5.05M	Hold	507,041	–	–	1.18%	22
2022 Q2	$5.01M	Hold	507,041	–	–	1.34%	19
2022 Q1	$4.98M	Hold	507,041	–	–	1.25%	18
2021 Q4	$4.95M	Hold	507,041	–	–	0.96%	24
2021 Q3	$4.94M	Hold	507,041	–	–	0.78%	29
2021 Q2	$5.04M	Hold	507,041	–	–	0.62%	28
2021 Q1	$4.99M	Buy	507,041 +501,818	+9,608%	+$5.19M	0.92%	25
2020 Q4	$507K	Buy	+5,223	New	+$53.2K	50.99%	1

Samsara BioCapital's JYAC Position: Q4 2022 in Review

Samsara BioCapital sold out of Jiya Acquisition Corp. Class A Common Stock (JYAC) in Q4 2022, closing a stake of 507,041 shares — an estimated $5.05M sold.

Samsara BioCapital first reported a position in JYAC in Q4 2020 and held it in 8 quarters. The position peaked at $5.05M in Q3 2022. 0 funds tracked by Wall St. Rank hold JYAC as of Q4 2022.

Samsara BioCapital reported no remaining Jiya Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Samsara BioCapital sold 507,041 Jiya Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $5.05M.
Samsara BioCapital first reported a position in Jiya Acquisition Corp. Class A Common Stock in Q4 2020 and held it in 8 quarters.
Samsara BioCapital's Jiya Acquisition Corp. Class A Common Stock position peaked at $5.05M in Q3 2022.
0 funds tracked by Wall St. Rank held Jiya Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Samsara BioCapital's 13F filing for Q4 2022, filed 14 Feb 2023.